We build state-of-the-art artificial intelligence to assist pathologists in clinical diagnostics and precision medicine. Our tools automate repetitive tasks such as cell and biomarker quantification to improve diagnostic speed, reproducibility and patient stratification.

Founded in 2018 and headquartered in Hamburg with an office in Cambridge, MA, we develop CE-marked and research-use AI products for histopathology including PD-L1, HER2, Ki-67 and metastasis detection.

Deep integrations into partner pathology software and a standalone AI Console for image analysis, with a focus on explainability, regulatory compliance and clinical utility.

Contact: [email protected]